What GLP-1 Does Noom Use? Noom’s Compounded and Brand-Name Medications, Decoded
Published: · Last reviewed:
By The RX Index Editorial Team · Last verified: June 2026 · Independent guidance for choosing your GLP-1 path.
What GLP-1 does Noom use? Noom doesn’t use just one. It depends on which Noom plan you pick. Its lower-cost GLP-1Rx plans use compounded semaglutide — a version a pharmacy mixes to order, which the FDA has not reviewed for safety, effectiveness, or quality. Its branded plan (Noom Med / Telehealth) connects eligible people to FDA-approved medicines like Wegovy, Zepbound, and Ozempic, where you pay for the drug separately. Which one fits you depends on whether you want FDA-approved or compounded, a shot or a pill, insurance or cash, and your state.
That’s the short version. Stick with us — because the part that trips people up isn’t which drug Noom uses. It’s that the cheap price you saw and the “real Ozempic” you pictured are usually two different plans. Below, we’ll show you exactly how to tell which Noom plan you’re looking at, what it really costs, and what to check before you hand over a card.
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
Noom may fit you if:
- ✓You want medicine plus Noom’s habit-change app and coaching
- ✓You’re open to a clinician choosing your treatment
- ✓You understand the difference between compounded and FDA-approved
Noom may not fit you if:
- ✗You specifically want a brand-name, FDA-approved drug (Wegovy, Zepbound, Ozempic)
- ✗You want insurance and prior authorization handled before you pay
- ✗You don’t like being billed three months at a time
- ✗You don’t want a compounded medication
The numbers to remember
Noom’s medicine-included GLP-1 plans run roughly $79–$149 to get started, then about $179–$299 a month after the first supply, with the medicine included. The branded plan is a separate membership — about $69–$149 to get started, then $99 a month — and the drug is billed on top of that. Noom’s own pages don’t always agree on these numbers, so always confirm the price on your own checkout screen.
✓ What we actually verified (Last verified June 2026)
- ✓Noom runs two different kinds of GLP-1 treatment paths: medicine-included plans using compounded semaglutide, and a branded plan where medicine is separate. (Source: Noom.com plan and support pages, June 2026.)
- ✓On the compounded side, Noom uses semaglutide injections — full-dose and a lower “microdose.” Noom’s support materials also reference liraglutide under the GLP-1Rx program. (Source: Noom support pages, June 2026.)
- ✓The branded path can include Wegovy (pen and pill), Zepbound, Ozempic, and Foundayo, with the drug billed through insurance or cash. (Source: Noom.com branded-medication support page, June 2026.)
- ✓The FDA does not approve or review any compounded drug for safety, effectiveness, or quality before it’s sold. In April 2026 the FDA proposed removing semaglutide, tirzepatide, and liraglutide from the list that lets large pharmacies make them in bulk. (Source: FDA.gov, 2025–2026.)
Everything with a price below should be re-checked at Noom’s live checkout before you pay — Noom’s public pages don’t always agree with each other, which is half the reason this page exists.
What GLP-1 does Noom use? (the full answer)
Noom uses different GLP-1 medicines depending on the plan. Its medicine-included plans (Microdose GLP-1Rx and the full-dose GLP-1Rx) use compounded semaglutide, a pharmacy-mixed version that is not FDA-approved. Its branded Noom Med plan connects eligible patients to FDA-approved drugs like Wegovy, Zepbound, and Ozempic, billed separately. There is no single “Noom GLP-1.”
First, a definition, because everything turns on it. Compounded means a licensed pharmacy mixes a medicine to order. It’s legal in specific situations, but the FDA does not check a compounded drug before it goes out the door — not for safety, not for strength, not for whether it works. FDA-approved drugs like Wegovy and Zepbound went through that full review. They are not the same thing, and no honest page should tell you they are.
Here’s how Noom’s plans line up. This is the table we wish existed when we started — because to build it, you’d otherwise have to open Noom’s Med page, pricing page, plan pages, and support articles, then cross-check it all.
The Noom GLP-1 Medication Decoder
| Noom plan | What you actually get | FDA-approved or compounded? | Route | Medicine included? | Roughly what it costs |
|---|---|---|---|---|---|
| Microdose GLP-1Rx | Compounded semaglutide, low dose | Compounded (not FDA-reviewed) | Injection | ✓ Yes | $79 to start, then ~$179–$199/mo |
| GLP-1Rx (full dose) | Compounded semaglutide, standard dose (Noom's materials also reference liraglutide — confirm the exact drug) | Compounded (not FDA-reviewed) | Injection | ✓ Yes | $129 to start, then ~$249–$279/mo |
| GLP-1Rx Plus | Listed as compounded tirzepatide — see warning below | Compounded (not FDA-reviewed) | Injection | ✓ Yes | ~$149 to start, then ~$299/mo |
| Proactive Health Microdose | Compounded semaglutide, very low dose + at-home biomarker testing | Compounded (not FDA-reviewed) | Injection | ✓ Yes | ~$149 every 4 weeks (longer first term) |
| Telehealth for Branded Meds (Noom Med) | Wegovy (pen + pill), Zepbound, Ozempic, Foundayo, and others if appropriate | FDA-approved | Injection + oral | ✗ No | ~$69–$149 to start, then ~$99/mo + the drug |
| Weight-Loss Pill plan | Metformin (this is NOT a GLP-1) | FDA-approved (not a GLP-1) | Pill | ✓ Yes | ~$69 to start, then ~$99/mo |
Sources: Noom’s plan pages and pricing page, verified June 2026. Noom’s own pages show different numbers for the same plan — see the cost section below — so confirm the live price, dose, and billing schedule at checkout.
Quick Decode — What Your Noom Screen Is Really Showing You
“GLP-1Rx” in the plan name?
Compounded semaglutide (or liraglutide). Medicine included in the price.
“Telehealth for Branded Meds”?
FDA-approved drugs (Wegovy, Zepbound, Ozempic). Medicine billed separately.
“GLP-1Rx Plus”?
Compounded tirzepatide (if available in your state). Confirm at checkout before relying on it.
“Metformin” or “Weight-Loss Pill”?
Not a GLP-1. Don’t compare its price to GLP-1 plans.
⚠ One honest flag on compounded tirzepatide
Noom’s own support materials describe a “GLP-1Rx Plus” plan using compounded tirzepatide. But availability may depend on your state and the current sign-up flow, and compounded tirzepatide faces the toughest FDA restrictions of all. If you specifically want it, confirm at checkout that GLP-1Rx Plus is actually available to you before you count on it. (Brand-name tirzepatide — Zepbound — is available through the branded plan.)
The big takeaway: a low Noom price usually means a compounded plan. A brand-name drug usually costs more and is billed separately. Most of the confusion online comes from mixing those two up.
Not sure which Noom plan you’re looking at — or whether compounded or brand-name fits your state, insurance, and budget?
Use The RX Index’s Find My GLP-1 Path tool to compare your medication options with source-verified pricing before you choose.
Match me to my GLP-1 path in 60 seconds →Which Noom plan are you looking at? (decode your checkout screen)
The fastest way to know what GLP-1 Noom is offering you is to read the plan name on your screen. Plans with “GLP-1Rx” in the name are medicine-included compounded plans. The plan called “Telehealth for Branded Meds” is the FDA-approved path where you pay for the drug separately. “Metformin” isn’t a GLP-1 at all.
This is the part no review site spells out, so let’s make it dead simple. Find the words on your Noom screen and match them below.
If your screen says “Microdose GLP-1Rx”
If your screen says “GLP-1Rx”
If your screen says “GLP-1Rx Plus”
If your screen says “Telehealth for Branded Meds”
If your screen says “Metformin” or “Weight-Loss Pill”
Does Noom use Ozempic, Wegovy, Zepbound, or Mounjaro?
Yes — Noom’s branded plan can connect eligible patients to Wegovy, Zepbound, Ozempic, and Foundayo, when a clinician decides it’s appropriate. But that only applies to the branded (Noom Med) plan, where you pay for the drug separately. Noom’s cheaper “GLP-1Rx” plans do not use these brand-name drugs.
Let’s go one by one, because people search each of these by name. One useful detail most pages skip: Noom routes branded prescriptions through the drugmaker’s own pharmacy partners.
Does Noom use Wegovy?
Yes — Wegovy can be part of Noom's branded path, including the Wegovy injection and the Wegovy pill, when prescribed. The drug cost is separate from your Noom membership, and Noom may route it through NovoCare (Novo Nordisk's pharmacy). Wegovy is FDA-approved for long-term weight management.
Does Noom use Zepbound?
Yes — Noom's branded path describes access to Zepbound (vials and the KwikPen) through LillyDirect (Eli Lilly's direct pharmacy), with the medicine billed separately from Noom's care fee. Zepbound is FDA-approved for chronic weight management.
Does Noom use Ozempic?
Ozempic can come up in Noom's branded path, but here's the honest detail most pages skip: Ozempic is FDA-approved for type 2 diabetes, not weight loss. Off-label prescribing for weight loss happens at a clinician's discretion. If weight loss is your goal, ask whether Wegovy or Zepbound — which are weight-loss approved — fit you better.
Does Noom use Mounjaro?
Same story as Ozempic. Mounjaro is FDA-approved for type 2 diabetes, and any weight-loss use is off-label. The weight-loss-approved version of that same medicine is Zepbound.
Does Noom use liraglutide?
Noom's medicine-administration support materials reference liraglutide under the GLP-1Rx program. Liraglutide is an older GLP-1 (brand names Saxenda and Victoza). If your Noom screen or prescription names it, don't assume you're getting semaglutide, Wegovy, Ozempic, or Zepbound — confirm the exact medicine and whether it's a brand-name or compounded version before you pay.
What about Foundayo or the Wegovy pill?
Noom lists oral options including the Wegovy pill, and its branded support page lists Foundayo through LillyDirect. Foundayo (orforglipron) is a newer FDA-approved oral GLP-1 for weight management — the FDA approved it on April 1, 2026 for adults with obesity, or overweight with at least one weight-related condition. If a pill matters to you, ask which oral options are available in your state.
Is Noom’s GLP-1 compounded or FDA-approved? (and what that means for you)
Noom offers both — and the difference is the single most important thing to understand before you pay. Its medicine-included GLP-1Rx plans use compounded semaglutide, which is not FDA-approved. Its branded plan uses FDA-approved drugs like Wegovy and Zepbound, billed separately. A simple test: if the price includes the medicine shipped to you, assume it’s compounded until Noom says otherwise.
Why does this matter so much? Because “FDA-registered” and “FDA-approved” sound alike but mean very different things. Noom says its compounded semaglutide is made in an FDA-registered facility. That just means the FDA knows the facility exists and can inspect it. It does not mean the FDA reviewed that specific medicine for safety, effectiveness, or quality. An FDA-approved drug like Wegovy went through years of testing. A compounded version did not. That’s not a scare tactic — it’s the actual line the FDA draws.
To its credit, Noom does publish quality details: it says its pharmacy partners are state-board regulated, follow USP standards, use ingredients from FDA-registered facilities, and run third-party batch testing — and that GLP-1Rx patients can ask the care team for a Certificate of Analysis (a lab report on their specific medicine). Those are real, useful checks. They are still not the same as FDA approval.
The honest part most Noom ads skip
Noom’s cheap plans do NOT hand you a discount version of Ozempic. Those plans use compounded semaglutide, which the FDA has not reviewed — and, as you’ll see below, that whole category is under real regulatory pressure in 2026. If FDA-approved, brand-name medicine is your top priority, Noom’s branded plan — or a brand-name specialist — is the better fit.
But here’s why that flaw doesn’t kill Noom for the right person: because those compounded plans skip insurance entirely, Noom can offer a flat, predictable cash price with the medicine included and a lower starting dose that brand-name plans usually don’t bother with. Different shoppers want different things. The trick is knowing which one you are.
Want FDA-approved Wegovy or Zepbound instead of a compounded plan — with help using your insurance?
Quick facts on Ro (verified June 2026): FDA-approved drugs only — Wegovy (pen + pill), Foundayo, Zepbound, and Ozempic. A free insurance checker that even non-members can use. An insurance team that checks your coverage, files your prior authorization, and helps if you’re denied. Ro Body membership is $39 the first month, then $149/month, or as low as $74/month if you prepay for a year — with the medicine billed separately. In Ro’s 2025 coverage report, 43% of users had coverage for a weight-loss GLP-1, and half of those paid $50/month or less.
Check your GLP-1 coverage free with Ro →We earn a commission if you use this link, at no cost to you.
How much does Noom’s GLP-1 really cost? (and why the prices look different)
Noom’s “from $69/month” headline is the membership fee for the branded plan — it does not include the medicine. The compounded full-dose GLP-1Rx plan runs about $249–$279/month (billed roughly $837 every 12 weeks on Noom’s plan page), with the medicine included. The microdose plan starts lower. This gap between the ad and the real bill is the #1 thing people get blindsided by.
There’s a second twist worth knowing: Noom’s own pages don’t agree with each other. Here’s the conflict, side by side.
Noom’s own pages show different prices
| Plan | Noom plan page says | Noom pricing page says | What to trust |
|---|---|---|---|
| Microdose GLP-1Rx | $79 to start, then $179/mo ($537 per 12 weeks) | $79 to start, then $199/mo after the first supply | Your live checkout screen |
| GLP-1Rx (full dose) | $129 to start, then $279/mo ($837 per 12 weeks) | $129 to start, then $249/mo after the first supply | Your live checkout screen |
| Branded telehealth | $69 to get started | $149 to get started, then $99/mo | Your live checkout screen |
That’s not a mistake on your end. It’s why the only number you should trust is the one on your own checkout page.
- ●The medicine is included on the compounded plans, but not the branded one. On GLP-1Rx plans, the price covers the compounded semaglutide. On the branded plan, you pay the membership and then the drug.
- ●You're billed every 12 weeks, not monthly. Noom's pricing pages show several GLP-1 plans billed a full quarter up front. Before you pay, check whether canceling stops only future renewals, and what happens to a charge you've already made.
- ●Branded meds can carry a visit fee. Noom's branded support page notes that some medicines require a video visit, and that missing or late-canceling one may cost a fee (Noom lists $72).
🌟 Quick plan reminder before you compare costs
Low price + medicine included = compounded plan. Low membership + drug billed separately = branded plan. Comparing them directly is what creates the sticker shock.
Before you pay Noom, see how its real cost stacks up against other GLP-1 treatment paths for your state and budget.
Compare your options with Find My GLP-1 Path →What you must check before you pay Noom
Before you pay, confirm five things: the exact medicine, whether it’s compounded or brand-name, whether the medicine is included in the price, how often you’re billed, and whether your state is eligible. Getting these wrong is how people end up with a compounded plan when they wanted Wegovy, or a quarterly bill when they expected monthly.
Take 60 seconds and screenshot your checkout screen. Then make sure you can answer each of these:
- 1
What is the exact medication name?
- 2
Is it compounded semaglutide, compounded tirzepatide, liraglutide, metformin, or a brand-name drug?
- 3
Is the medicine included in the price, or billed separately?
- 4
How often are you billed — monthly, every 12 weeks, or a longer first term?
- 5
What's the first charge, and what's the renewal charge?
- 6
Which pharmacy fills it — and for a compounded plan, can you request a Certificate of Analysis?
- 7
Is your state eligible?
- 8
Can you cancel before the next cycle, and what happens to a charge you've already paid?
- 9
Is a video visit required, and is there a fee for missing it?
- 10
If you have insurance, does it apply, and who handles the prior authorization for a brand-name drug?
Is Noom’s compounded semaglutide safe and legal in 2026?
Compounded semaglutide can be made legally in specific, patient-by-patient cases, but it is not FDA-approved, and the rules tightened sharply in 2025–2026. The FDA declared the semaglutide shortage over in February 2025, and in April 2026 it proposed cutting off the last large-scale path for compounding it. So Noom’s compounded plans sit on shifting ground — which matters if you’re signing up for months at a time.
Here’s the plain-English history, because it explains why Noom leans so hard on “microdose.”
| When | What happened | What it meant for compounded GLP-1 |
|---|---|---|
| 2022 | FDA put semaglutide and tirzepatide on the shortage list | Pharmacies could legally make copies → a compounding boom (~$150–$300/mo vs $1,000+ for brand) |
| Oct–Dec 2024 | FDA said the tirzepatide shortage was over | The legal basis for compounding tirzepatide started closing |
| Feb 2025 | FDA said the semaglutide shortage was over | The shortage-based reason to compound semaglutide ended too |
| March 2026 | FDA sent warning letters to 30 telehealth companies over marketing of compounded GLP-1s | Enforcement ramped up |
| Apr 30, 2026 | FDA proposed removing semaglutide, tirzepatide, and liraglutide from the 503B Bulks List | Would block big pharmacies from making them in bulk; public comment through late June 2026, final decision expected later in 2026 |
Two terms worth defining: a 503B pharmacy is a large “outsourcing facility” that makes big batches; a 503A pharmacy mixes drugs for one patient at a time. After the shortage ended, the main path left for compounded semaglutide is the narrower, patient-specific 503A route — and even that can’t be used to mass-produce a near-copy of a drug you can already buy.
Our editorial read (not Noom’s words):
The reason Noom — like almost every compounding telehealth program in 2026 — pivoted to “microdose” and “personalized dosing” language is that personalized, patient-specific dosing is the narrower path that survived after the shortage ended. We can’t read Noom’s legal strategy, but the timing lines up. (Liraglutide, interestingly, is the one of the three still on the FDA shortage list — part of why it can still be compounded right now.)
Why this matters for you, practically: access to compounded semaglutide could shrink later in 2026. Paying 12 weeks up front for a compounded plan carries that risk. If you want certainty, the FDA-approved path doesn’t have this cloud over it.
Worried compounded options might not last in your state?
See current, source-verified GLP-1 paths where you live →A note on safety, kept factual: the FDA has pointed to reports of dosing errors from multi-dose vials and quality concerns with some compounded products, and several medical groups have advised against compounded GLP-1s. That doesn’t make every compounding pharmacy unsafe — but it’s why you should confirm the pharmacy, the dose, and your clinician’s instructions, and discuss risks with a licensed provider before starting any GLP-1.
Where Noom is available, plus insurance, HSA, and FSA
Noom’s compounded GLP-1 isn’t available in every state, insurance only applies to brand-name drugs (not compounded), and Noom does not take HSA or FSA cards directly — you pay first and submit for reimbursement.
- State limits: Noom's GLP-1Rx and Microdose plan pages currently say those plans are available in every U.S. state except Alabama, Louisiana, and Mississippi. Availability can still change by plan and medicine, so verify at checkout.
- Insurance: Noom can use insurance only for brand-name drugs on the branded plan, where its team can help with prior authorization. Compounded semaglutide is cash-pay and isn't billed to insurance.
- HSA/FSA: Noom does not accept HSA or FSA cards at checkout. Your Noom Med subscription may still qualify for reimbursement under many plans, but you pay with a personal card, then submit Noom's receipt to your HSA/FSA administrator yourself. Reimbursement depends on your plan and isn't guaranteed.
Does Noom accept insurance for GLP-1 medications?
Only for brand-name medicines (Wegovy, Zepbound, Ozempic) through the branded plan, where Noom’s care team may help with prior authorization. Noom’s compounded semaglutide is cash-pay, not billed to insurance. Noom also doesn’t take HSA/FSA cards directly — you pay first, then submit for possible reimbursement.
Who Noom is best for — and the best alternatives if it’s not your fit
Noom is the strongest fit for people who want medicine paired with a behavior-change app and coaching, and who are comfortable with a clinician-directed plan. If you mainly want a specific FDA-approved drug with insurance help, a brand-name specialist like Ro is usually cleaner.
When we score programs, we use the RX Index Score — five things, always in this order: clinical legitimacy, care quality, transparency, access, and cost. On that scale, Noom’s weak spot for this exact question is transparency: the medicine, FDA status, and true price are hard to read until you know the plan. Its strength is the care quality wrapped around the medicine — the app, coaching, and follow-up.
Find yourself in this table:
| Your situation | Best next step |
|---|---|
| "I want Noom's app and coaching with medicine support." | Noom can fit. Confirm the exact drug, price, and billing first. |
| "I want a brand-name, FDA-approved drug (Wegovy/Zepbound) and insurance help." | A brand-name specialist like Ro — check coverage free before you pay. Check coverage free with Ro → |
| "I saw a low Noom price but don't know if the medicine is included." | Use the plan decoder above and screenshot your checkout terms. |
| "I'm open to compounded but want the cheapest, most flexible cash-pay fit." | Compare current options with Find My GLP-1 Path (and confirm availability given the 2026 FDA review). Find My GLP-1 Path → |
| "I want Ozempic or Mounjaro specifically." | Know those are diabetes-approved (off-label for weight loss). Ask about Wegovy or Zepbound instead. |
If you’ve decided you want compounded semaglutide — but cheaper, or month-to-month instead of Noom’s 12-week billing — there are lower-cost cash-pay programs worth comparing. We keep the current, source-verified ones (with their real prices, pharmacies, and state availability) inside our matching tool, because that’s a category where prices and availability are changing fast right now. See our guide on best compounded semaglutide alternatives for the current list.
If Noom’s coaching-plus-medicine model fits you, verify the plan details first. If it doesn’t, find a better-fit provider in 60 seconds.
Find My GLP-1 Path →What real Noom users say
Across public reviews and forums, Noom users tend to praise the habit-change app, the coaching, and clinician access — and complain most about the gap between the advertised price and the real one, plus the cancellation experience. We use reviews for how people feel about buying, never as proof a medicine is safe or effective.
The pattern is consistent across review sites and Reddit: people like the program and the support, and they get frustrated when the “$69” they expected turns into a much larger bill once medicine and quarterly billing are added in. On Reddit, the single most common question is some version of “Wait — is there a catch? Do I owe more for the medication?” That’s the exact confusion this page exists to fix: yes, on the branded plan, the medicine is a separate cost; and yes, on the compounded plans, you’re usually billed three months at a time.
User reviews are shown to reflect common customer-experience themes. They are not evidence of medical safety, effectiveness, or typical weight-loss results, and individual review platforms do not verify the reviews they publish.
How we verified this guide
This guide was built by comparing Noom’s own Med page, pricing page, plan pages, and support articles against each other and against primary FDA sources — and by separating commercial facts (price, what’s included) from medical and regulatory facts (FDA status) from our own editorial judgment (who each path fits). We are not affiliated with Noom and were not paid by Noom.
What we checked: Noom’s plan names and what medicine each one uses; how Noom presents pricing across its pages (including where those pages disagree); how Noom separates compounded from brand-name treatment paths; and the FDA’s current position on compounded GLP-1s.
What still needs a real-time check before you rely on it: the exact live price and billing schedule for each plan, your state’s eligibility, the pharmacy filling a compounded plan, and whether GLP-1Rx Plus (compounded tirzepatide) is currently offered to you. We flag those plainly above so you can confirm them yourself.
Why trust this page over the others? Because it answers a narrower question than a general Noom review or a “best GLP-1 provider” list: it tells you, at the plan level, what Noom uses, whether it’s compounded or FDA-approved, what’s included, and what to confirm before you pay — with the compounded-vs-approved line drawn honestly instead of blurred.
Frequently asked questions
What GLP-1 medication does Noom use?
Noom uses different GLP-1 medicines depending on the plan. Its medicine-included GLP-1Rx plans use compounded semaglutide, and its support materials also reference liraglutide, while its branded plan connects eligible patients to FDA-approved drugs like Wegovy, Zepbound, and Ozempic. There is no single Noom GLP-1.
Does Noom use compounded semaglutide?
Yes. Noom's Microdose GLP-1Rx and full-dose GLP-1Rx plans use compounded semaglutide injections, with the medicine included in the price. Compounded semaglutide is not FDA-approved and has not been reviewed by the FDA for safety, effectiveness, or quality.
Does Noom use tirzepatide?
Noom's support materials describe a GLP-1Rx Plus plan using compounded tirzepatide, but availability may depend on your state and the current sign-up flow, so confirm it at checkout. Brand-name tirzepatide — Zepbound — is available through Noom's branded plan, billed separately.
Does Noom prescribe Ozempic or Wegovy?
Noom's branded plan can connect eligible patients to Wegovy and Ozempic when a clinician decides it's appropriate. Wegovy is FDA-approved for weight loss; Ozempic is FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss. The medicine cost is separate from the Noom membership.
Is Noom's GLP-1 FDA-approved?
It depends on the plan. The brand-name drugs Noom can help eligible patients access, like Wegovy and Zepbound, are FDA-approved. Noom's compounded GLP-1Rx plans are not FDA-approved.
Is medication included in Noom's price?
On the compounded GLP-1Rx plans, yes — the price includes the compounded semaglutide. On the branded plan, no — you pay roughly $69 to $149 to start and about $99 a month for the membership, plus the cost of the medicine through insurance or cash.
How much does Noom's GLP-1 cost?
The full-dose compounded plan is about $249 to $279 a month (Noom's own pages differ), billed roughly $837 every 12 weeks on its plan page. The microdose plan starts lower. The branded plan is about $99 a month for the membership, with the drug billed separately. Confirm the live price at checkout.
Why does Noom's GLP-1 pricing look different on different pages?
Because Noom has several plan types, and its plan pages and pricing page show different numbers for the same plan. The reliable number is the one on your own checkout screen. Confirm the plan name, what's included, the first charge, the renewal charge, and the billing schedule before you pay.
Can I use my HSA or FSA for Noom's GLP-1?
Noom does not accept HSA or FSA cards directly at checkout. Your Noom Med subscription may still qualify for reimbursement under many plans, so you pay with a personal card and submit Noom's receipt to your HSA/FSA administrator. Reimbursement depends on your plan and is not guaranteed.
Is Noom's compounded semaglutide safe and legal?
It is prescribed and managed by a licensed clinician and filled through Noom's designated partner pharmacies, but it is not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness, or quality before they are sold. As of mid-2026 the FDA has proposed removing it from the list that allows large-scale compounding, so availability could change. Discuss risks with a licensed provider.
What should I ask Noom before paying?
Ask for the exact medication name, whether it is compounded or brand-name, whether the medicine is included, who fills it, how often you are billed, whether your state is eligible, and what happens if insurance denies a brand-name drug.
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz →Sources: Noom — Med page, pricing page, plan pages (Microdose GLP-1Rx, GLP-1Rx, GLP-1Rx Plus, Zepbound, Ozempic, Mounjaro), and support pages (how to administer your medication; telehealth for branded meds; using HSA/FSA; GLP-1 access and transparency; compounded semaglutide safety information), accessed June 2026. U.S. Food & Drug Administration — “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss”; “FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List” (April 30, 2026); “FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s” (March 2026); “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.” Ro — pricing page, GLP-1 Insurance Coverage Checker, and 2025 Coverage Checker report, accessed June 2026. Prices and provider details are commercial facts that change frequently; verify at the source before acting.
Your situation changes the answer
Find My GLP-1 Path
The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred route (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.
- What it asks: your state, insurance situation, medication preference, budget, and support needs
- What you get: a personalized shortlist of GLP-1 providers matched to your situation, with verified pricing and the right questions to ask
- Cost: free · about 60 seconds · no signup